Clinical Trials

1 193 194 195 196 197 209
Number of results: 4174

Excel print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2011-12-09 Alpharadin® (radium-223 chloride) endocrine-refractory breast cancer patients with bone metastases 2a Algeta (Norway) Cancer - Oncology
2011-12-09 BI 201335 chronic hepatitis C virus 3 Boehringer Ingelheim (Germany) Infectious diseases
2011-12-08 Vyvanse® (lisdexamfetamine dimesylate)

adjunctive therapy to primary antidepressant treatment in adults with partial or full remission of recurrent major depressive disorder (MDD) and significant, persistent cognitive impairments

2 Shire (UK-USA) Mental diseases - CNS diseases
2011-12-08 linagliptin (Tradjenta® in the US and Trajenta® in Europe) type 2 diabetes 3 Boehringer Ingelheim (Germany) Eli Lilly (USA) Metabolic diseases
2011-12-08 inhaled interferon beta (IFN-beta) exacerbation-prone asthmatics 2 Synairgen (UK) Allergic diseases - Inflammatory diseases - Respiratory diseases
2011-12-06 Lyxumia® (lixisenatide) in combination with Lantus® (insulin glargine) type 2 diabetes 3 Sanofi (France) Metabolic diseases
2011-12-06 APD209

cancer cachexia

2a Acacia Pharma (UK) Cancer Oncology
2011-12-06 BL-1021

neuropathic pain

1a BiolineRx (Israel) CNS diseases
2011-12-02 simeprevir (TMC435) and daclatasvir

genotype-1 chronic hepatitis C virus (HCV) infection

2 BMS (USA) Tibotec Pharmaceuticals (J&J) (USA) Medivir (Sweden) Infectious diseases
2011-11-28 blinatumomab (MT103) acute lymphoblastic leukemia 2 Micromet (USA-Germany) Cancer - Oncology
2011-11-28 Eylea® (aflibercept)

neovascular form of age-related macular degeneration (wet AMD)

3 Bayer HealthCare (Germany) Regeneron Pharmaceuticals (USA) Ophtalmological diseases
2011-11-25 aerosolised interferon beta (IFN-beta)

viral pneumonia

preclinical Synairgen (UK) Respiratory diseases - Infectious diseases - Lung diseases
2011-11-24 tregalizumab (BT-061)

chronic plaque psoriasis

2 Biotest (Germany) Autoimmune diseases - Dermatological diseases
2011-11-24 GFT505 NASH (non-alcoholic steatohepatitis)/NAFLD (non-alcoholic fatty liver disease)

preclinical Genfit (France) Liver diseases - Metabolic diseases
2011-11-24 PL37

neuropathic pain

1 Pharmaleads (France) CNS diseases
2011-11-22 PXT-3003 (fixed-dose combination of (R-S) baclofen, naltrexone hydrochloride and D-sorbitol) Charcot-Marie-Tooth disease 2 Pharnext (France) Rare diseases - Genetic diseases - Neurological diseases
2011-11-19 Enzyme Replacement Therapy (ERT) Pompe disease and other metabolic disorders UGent and Vrije Universiteit (Belgium) Oxyrane (Belgium-UK-USA) Genetic diseases - Rare diseases - Metabolic diseases
2011-11-16 albiglutide type 2 diabetes 3 GSK (UK) Metabolic diseases
2011-11-15 Fibrocaps™ 2 ProFibrix (The Netherlands) Hemostasis
2011-11-13 Xarelto® (rivaroxaban)

Secondary Prevention of Acute Coronary Syndrome (ACS)

3 Bayer HealthCare (Germany) Cardiovascular diseases